by Vora Corporate Finance | May 15, 2026 | Insights
Transaction: Swiss pharmaceutical company Novartis AG will divest its 70.68% stake in Novartis India Limited to a consortium led by ChrysCapital, along with WaveRise Investments and Two Infinity Partners, marking a change-in-control and its exit from the India-listed...
by Vora Corporate Finance | May 15, 2026 | Insights
Transaction: Alkem Laboratories, through its wholly-owned subsidiary Alkem MedTech, has entered into a definitive agreement to acquire an approximate 55% stake in Occlutech Holding AG, a global leader in structural heart disease devices. Funded by an all-cash...
by Vora Corporate Finance | May 15, 2026 | Insights
There were 07 main board IPOs in February 2026 including Fractal Analytics Limited, Aye Finance Limited, Gaudium IVF & Women Health Limited, Shree Ram Twistex Limited, Cleanmax Enviro Energy Solutions Limited, PNGS Rewa Diamonds Jewellery Limited and Omnitech...
by Vora Corporate Finance | May 15, 2026 | Insights
The BSE Sensex closed February at 81,287.19, while the Nifty 50 ended the month at 25,178.65, reflecting marginal declines of 1.19% and 0.56%, respectively, compared to January. Following the sharp correction seen earlier in the year, markets traded in a relatively...
by Vora Corporate Finance | May 15, 2026 | Insights
The war between Iran and the US-Israel coalition that began in late February 2026 has quickly changed the global economic landscape. While the trade deal between India and the US in January provided some relief, this new conflict has created a massive wave of fresh...
